Practice guidance for the use of terlipressin for liver cirrhosis-related complications.

Xing Shun QiZhaohui BaiQiang ZhuGang ChengYu ChenXiaowei DangHuiguo DingJuqiang HanLei HanYingli HeFanpu JiHongxu JinBimin LiHongyu LiYiling LiZhiwei LiBang LiuFuquan LiuLei LiuSu LinDapeng MaFanping MengRuizhao QiTianshu RenLichun ShaoShanhong TangYufu TangYue TengChunhui WangRan WangYunhai WuXiangbo XuLing YangJinqiu YuanShanshan YuanYida YangQingchun ZhaoWei ZhangYongping YangXiaozhong GuoWeifen Xie

Published in: Therapeutic advances in gastroenterology (2022)

The current clinical practice guidance supports the use of terlipressin for gastroesophageal variceal bleeding and HRS in liver cirrhosis. High-quality studies are needed to further clarify its potential effects in other liver cirrhosis-related complications.

Keyphrases

clinical practice
primary care
risk factors
healthcare
drug induced